Azenta (NASDAQ:AZTA) Price Target Raised to $52.00 at Evercore ISI

Azenta (NASDAQ:AZTA) had its target price boosted by Evercore ISI from $50.00 to $52.00 in a research report sent to investors on Thursday,Benzinga reports. The brokerage currently has an in-line rating on the stock.

Several other research firms have also issued reports on AZTA. Needham & Company LLC increased their target price on shares of Azenta from $55.00 to $59.00 and gave the stock a “buy” rating in a research note on Thursday. Stephens reissued an “overweight” rating and set a $60.00 target price on shares of Azenta in a research note on Thursday, January 2nd.

Azenta Stock Up 0.5 %

Shares of AZTA opened at $54.04 on Thursday. The business’s 50-day moving average is $50.49 and its two-hundred day moving average is $49.10. Azenta has a fifty-two week low of $38.82 and a fifty-two week high of $67.77.

Azenta (NASDAQ:AZTA) last announced its quarterly earnings results on Wednesday, February 5th. The company reported $0.08 earnings per share for the quarter, topping the consensus estimate of $0.05 by $0.03. Azenta had a positive return on equity of 1.03% and a negative net margin of 25.01%. On average, analysts anticipate that Azenta will post 0.41 earnings per share for the current fiscal year.

Insider Transactions at Azenta

In other Azenta news, CFO Herman Cueto sold 712 shares of the firm’s stock in a transaction that occurred on Tuesday, November 19th. The shares were sold at an average price of $40.07, for a total value of $28,529.84. Following the completion of the transaction, the chief financial officer now owns 23,892 shares of the company’s stock, valued at $957,352.44. This trade represents a 2.89 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this link. Also, Director William L. Cornog purchased 12,500 shares of the firm’s stock in a transaction on Monday, November 18th. The stock was acquired at an average cost of $39.60 per share, with a total value of $495,000.00. Following the transaction, the director now directly owns 14,755 shares in the company, valued at $584,298. This trade represents a 554.32 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders sold 1,423 shares of company stock worth $57,020 in the last 90 days. Insiders own 10.62% of the company’s stock.

Hedge Funds Weigh In On Azenta

A number of institutional investors and hedge funds have recently modified their holdings of the company. Farther Finance Advisors LLC grew its stake in shares of Azenta by 20.0% during the third quarter. Farther Finance Advisors LLC now owns 1,537 shares of the company’s stock worth $74,000 after purchasing an additional 256 shares in the last quarter. KBC Group NV boosted its stake in Azenta by 48.5% in the fourth quarter. KBC Group NV now owns 2,137 shares of the company’s stock valued at $107,000 after acquiring an additional 698 shares in the last quarter. Assenagon Asset Management S.A. acquired a new position in Azenta in the fourth quarter valued at $200,000. Net Worth Advisory Group acquired a new position in Azenta in the third quarter valued at $205,000. Finally, Aigen Investment Management LP acquired a new position in Azenta in the third quarter valued at $214,000. Institutional investors and hedge funds own 99.08% of the company’s stock.

Azenta Company Profile

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.